Clinical Trial Update: Post-market Prospective Clinical Study of Nagor Perle Mammary Implants

View source ↗

Summary

Sponsor GCA (Eurosilicone) is recruiting for a post-market prospective clinical study of Nagor Perle silicone mammary implants to assess safety and outcomes in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Nagor Perle Mammary Implants

Snippet

Sponsor: GCA (Eurosilicone) | Conditions: Breast Reconstruction, Breast Reconstruction Following Mastectomy | Status: RECRUITING